By continuing to use the site you agree to our Privacy & Cookies policy

Your browser seems to have cookies disabled. For the best experience of this website, please enable cookies in your browser.


Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.


Adverse effects warnings absent from 40% of drugs

Information on adverse effects of commonly prescribed drugs is often inadequate, a study has shown.

A study of the 50 most commonly prescribed drugs in England showed that 20 (40%) of the information leaflets supplied made no mention of adverse effects.

Only six (12%) used recommended EU terms and a further 20 used a wide range of other verbal descriptions.

Numerical indication of risk was included in only four (8%) of leaflets and more than half (52%) presented long lists of adverse effects in continuous text, the study showed.

Authors wrote: ‘Most patients receive no information, whereas some are given verbal descriptors, both of which lead to overestimation of the risk.

‘Very few of the patient information leaflets assess used currently described best practice.’

Drug Safety (2008) 31: 305-312

Have your say

You must sign in to make a comment.

Related Jobs

Sign in to see the latest jobs relevant to you!